GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 58 filers reported holding GEMINI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,891,000 | -2.9% | 2,372,267 | 0.0% | 0.16% | +6.6% |
| Q2 2022 | $4,009,000 | +21.6% | 2,372,267 | 0.0% | 0.15% | +50.5% |
| Q1 2022 | $3,297,000 | -52.2% | 2,372,267 | 0.0% | 0.10% | -24.6% |
| Q4 2021 | $6,903,000 | -20.1% | 2,372,267 | +11.0% | 0.13% | -8.2% |
| Q3 2021 | $8,637,000 | -37.5% | 2,137,823 | +0.1% | 0.15% | -29.5% |
| Q2 2021 | $13,813,000 | -22.3% | 2,135,000 | +62.7% | 0.21% | -21.3% |
| Q1 2021 | $17,783,000 | – | 1,312,363 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Opportunity Management V, LLC | 2,435,125 | $4,115,000 | 10.37% |
| Foresite Capital Management V, LLC | 2,435,125 | $4,115,000 | 2.88% |
| Atlas Venture Life Science Advisors, LLC | 5,254,365 | $8,880,000 | 1.48% |
| Orbimed Advisors | 5,826,224 | $9,846,000 | 0.18% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,372,267 | $4,009,000 | 0.15% |
| Boxer Capital, LLC | 1,300,000 | $2,197,000 | 0.14% |
| Ikarian Capital, LLC | 443,096 | $749,000 | 0.14% |
| K2 PRINCIPAL FUND, L.P. | 292,745 | $495,000 | 0.06% |
| HARVARD MANAGEMENT CO INC | 250,000 | $423,000 | 0.05% |
| Marquette Asset Management, LLC | 87,648 | $148,000 | 0.04% |